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ABSTRACT
Age-related impairment of macroautophagy/autophagy and loss of cardiac tissue homeostasis contri-
bute significantly to cardiovascular diseases later in life. MTOR (mechanistic target of rapamycin kinase)
signaling is the most well-known regulator of autophagy, cellular homeostasis, and longevity. The MTOR
signaling consists of two structurally and functionally distinct multiprotein complexes, MTORC1 and
MTORC2. While MTORC1 is well characterized but the role of MTORC2 in aging and autophagy remains
poorly understood. Here we identified TGFB-INHB/activin signaling as a novel upstream regulator of
MTORC2 to control autophagy and cardiac health during aging. Using Drosophila heart as a model
system, we show that cardiac-specific knockdown of TGFB-INHB/activin-like protein daw induces autop-
hagy and alleviates age-related heart dysfunction, including cardiac arrhythmias and bradycardia.
Interestingly, the downregulation of daw activates TORC2 signaling to regulate cardiac autophagy.
Activation of TORC2 alone through overexpressing its subunit protein rictor promotes autophagic flux
and preserves cardiac function with aging. In contrast, activation of TORC1 does not block autophagy
induction in daw knockdown flies. Lastly, either daw knockdown or rictor overexpression in fly hearts
prolongs lifespan, suggesting that manipulation of these pathways in the heart has systemic effects on
longevity control. Thus, our studies discover the TGFB-INHB/activin-mediated inhibition of TORC2 as
a novel mechanism for age-dependent decreases in autophagic activity and cardiac health.
Abbreviations: AI: arrhythmia index; BafA1: bafilomycin A1; BMP: bone morphogenetic protein; CQ: chlor-
oquine; CVD: cardiovascular diseases; DI: diastolic interval; ER: endoplasmic reticulum; HP: heart period; HR:
heart rate; MTOR: mechanistic target of rapamycin kinase; NGS: normal goat serum; PBST: PBS with 0.1%
Triton X-100; PDPK1: 3-phosphoinositide dependent protein kinase 1; RICTOR: RPTOR independent compa-
nion of MTOR complex 2; ROI: region of interest; ROUT: robust regression and outlier removal; ROS: reactive
oxygen species; R-SMAD: receptor-activated SMAD; SI: systolic interval; SOHA: semi-automatic optical heart-
beat analysis; TGFB: transformation growth factor beta; TSC1: TSC complex subunit 1
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Introduction
Aging is associated with an exponential increase in the inci-
dence of cardiovascular diseases (CVD) [1,2]. Age-related
changes in cardiovascular structure and output have been
linked to increased risk of coronary heart disease, sudden
cardiac death and stroke in the elderly population [3].
During normal aging, the left ventricular wall of human
hearts becomes thickened and the diastolic filling rate of left
ventricle gradually decreases, while the left ventricular systolic
performance at rest remains no change with age [3]. Several
mechanisms underlying these age-associated changes in car-
diovascular structure and function have been proposed, for
example, changes in growth factor signaling, decreased cellu-
lar quality control, altered calcium handling, elevated extra-
cellular matrix deposition or fibrosis, increased mitochondria
damage, and the production of reactive oxygen species (ROS)
[2]. Resolving the contributing mechanisms underlying the
age-dependent decline of cardiovascular function is critical
for the development of therapeutic interventions for the treat-
ment of cardiovascular diseases.
Cellular quality control systems, such as macroautophagy
(hereinafter referred to as autophagy), are essential to the
maintenance of tissue homeostasis during aging [4].
Autophagy is a highly conserved process that is responsible
for the degradation and recycling of damaged organelles,
protein aggregates, and other cytoplasmic substances [5]. It
is generally accepted that autophagy activity declines with age
[6]. However, how autophagic activity is altered in aging
hearts remains unclear. Disruption of autophagy pathways
often leads to loss of tissue homeostasis and tissue dysfunc-
tion. For example, knocking out autophagy gene Atg5 in the
mouse heart accelerates cardiac aging, including an increase
in left ventricular hypertrophy and decrease in fractional
shortening [7]. As a key autophagy regulator, MTOR
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(mechanistic target of rapamycin kinase) plays an important
role in the regulation of cardiac tissue homeostasis [2]. The
MTOR signaling consists of two structurally and functionally
distinct protein complexes, MTORC1 and MTORC2 [8].
Rapamycin-mediated suppression of MTORC1 induces
autophagy and protects mouse cardiomyocytes from oxidative
stress [9]. Drosophila genome contains evolutionarily con-
served Tor kinase and several major TOR complex subunits
(e.g., raptor and Lst8 for TORC1, rictor, Sin1 and Lst8 for
TORC2) [10]. Drosophila MTORC1 promotes electrical
pacing-induced heart failure [11], and high-fat-diet-induced
cardiomyopathy [12]. Unlike MTORC1, the role of MTORC2
in autophagy, tissue homeostasis, and cardiac aging remains
poorly understood. Two recent studies show that disruption
of MTORC2 subunit RICTOR (RPTOR independent compa-
nion of MTOR complex 2) induces cardiac dysfunction in
mice [13,14]. Interestingly, 2 MTOR complexes exhibit dis-
tinct regulation on lifespan. Inhibition of MTORC1 is known
to prolong lifespan [15], while deletion of RICTOR, the key
component of MTORC2, shortens lifespan of male mice [16].
However, the molecular basis for MTORC2-regulated aging
and tissue homeostasis remains to be further examined.
TGFB (transforming growth factor beta) is an evolutiona-
rily conserved signaling pathway that regulates a wide variety
of cellular processes, such as proliferation, differentiation,
apoptosis, inflammation, and fibrosis [17]. Recent studies
demonstrate that TGFB factors promote cardiac fibrosis dur-
ing aging [18], while reduction of TGFB signaling improves
cardiac health in aged mice through the regulation of
microRNA MIR29 [19]. As in mammals, TGFB family in
Drosophila has 2 major branches, BMP (bone morphogenetic
protein) and TGFB-INHB/activin signaling pathways [17]. In
both TGFB pathways, signaling starts with ligand binding to
a receptor complex composed of type I and type II receptor
kinases, followed by phosphorylation of receptor-activated
SMAD (R-SMAD). Recently, we and other groups show that
TGFB-INHB/activin signaling regulates muscle proteostasis
and longevity in Drosophila [20,21]. However, it remains to
be determined whether TGFB family proteins, in particular,
INHB/activin, regulate cardiac homeostasis and function.
While investigating the role ofDrosophilaTGFB-INHB/activin
signaling in the regulation of autophagy and age-related cardio-
myopathy, we find that TGFB-INHB/activin signaling genetically
interacts with TORC2, but not TORC1 to control age-dependent
decreases in autophagy and cardiac health. We further show that
the activation of TORC2 alone can induce autophagy and preserve
cardiac function during aging. Thus, our studies uncover a novel
crosstalk between TGFB-INHB/activin signaling and TORC2 that
is essential for the maintenance of autophagic activity, tissue
homeostasis, and cardiac health with aging.
Results
Heart-specific knockdown of TGFB-INHB/activin-like
ligand daw slows cardiac aging
Our previous study demonstrated that the TGFB-INHB/activin-
like protein daw regulates tissue homeostasis (especially in indir-
ect flight muscle) and longevity inDrosophila [20]. Interestingly,
we found that the mRNA expression of daw was significantly
upregulated in aging fly hearts (29.7-fold) (Figure 1A), suggest-
ing that TGFB-INHB/activin signaling may play a role in reg-
ulating cardiac aging. To investigate this possibility, we knocked
down the expression of daw specifically in the heart with a binary
GAL4/UAS system where we crossed UAS-daw RNAi lines into
a cardiac-specific tissue driver (Hand-gal4 or Hand4.2-gal4)
(Figure S1A,B). We analyzed cardiac performance in young
and old flies using a high-speed video imaging system (semi-
automatic optical heartbeat analysis, SOHA) [22]. M-Mode
traces from the SOHA analysis indicated that knockdown
of daw preserved cardiac contractility at advanced ages (Figure
1B). In wild-type flies, aged hearts showed increased arrhythmia
(Figures 1C, S1I and S1J, data from three wild-type genotypes),
lengthened diastolic intervals and heart period (bradycardia,
slow heart rate) (Figure 1D,E), and decreased cardiac output
(Figure 1F). Systolic intervals normally remain unchanged
(Figure S1E). There is a small age-related reduction in fractional
shortening (Figure S1F), but the diastolic and systolic diameters
were not significantly altered (Figure S1G,H). Interestingly, car-
diac-specific knockdown of daw attenuated the age-dependent
increase in arrhythmia, diastolic intervals, and heart period
(Figure 1C–E). Knockdown of daw also maintained relatively
normal cardiac output at advanced ages (Figure 1F). Similar
results were observed from three independent daw RNAi lines
(the knockdown efficiency of daw RNAi was verified by qRT-
PCR previously [20], as well as reconfirmed in the present study)
(Figure S1C,D). However, cardiac-specific overexpression of
daw did not lead to premature cardiac aging phenotypes
(Figure S1K), which may be because the ectopic expression of
daw in the heart did not generate active daw proteins.
The Hand-gal4 line drives gene expression in both cardio-
myocytes and pericardial cells (Figure S1A). To test the car-
diomyocyte-specific role of daw in cardiac aging, we then
crossed daw RNAi into a cardiomyocyte-specific driver tinc-
gal4 (or tincΔ4-gal4) (Figure S1A). Similar to the results from
Hand-gal4 (Figure 1C,G), cardiomyocyte-specific knockdown
of daw prevented the age-related increase in cardiac arrhyth-
mia (Figure 1H). We also tested whether daw expression in
pericardial cells can regulate cardiac aging using a pericardial
cell-specific driver Ugt36A1/Dot-gal4. Interestingly, knock-
down of daw in pericardial cells also alleviated age-induced
arrhythmia (Figure 1I), but not diastolic interval (Figure 1J).
Thus, reduction of daw signaling can alleviate age-related
cardiac dysfunction, particularly the age-induced arrhythmia,
through both cardiomyocyte-specific regulation and non-
autonomous signaling from pericardial cells.
It is known that TGFB-INHB/activin signaling typically
functions through its downstream transcription factor
SMAD2 (or Smox in Drosophila). We noticed that during
aging the phosphorylation of Smox/SMAD2 was elevated in
the fly heart nuclei (Figure 1K). To test the role of Smox in
cardiac aging, we performed SOHA analysis on flies with
cardiac-specific Smox knockdown. Surprisingly, knockdown
of Smox in the heart did not attenuate the age-dependent
increase in arrhythmia, diastolic intervals, and heart period
(Figure 1L). These findings suggest that daw may regulate
cardiac aging through a Smox-independent pathway (e.g.,
MAPK/p38 signaling [23]).
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Cardiomyocyte-specific knockdown of INHB/activin
receptor babo delays cardiac aging
In Drosophila, INHB/activin-like ligand daw signals
through the type I receptor babo, the fly homolog of mam-
malian ACVR1B/ALK4 (activin A receptor, type 1B) [17].
To investigate whether daw acts through its receptor babo
to modulate cardiac aging, we first tested if babo plays
a similar role in preventing the age-dependent increase in
cardiomyopathy. Consistent with the results from
daw knockdown, we found that cardiomyocyte-specific
knockdown of babo blocked the age-related increase in
cardiac arrhythmia, diastolic intervals, and heart period
(Figure 2A–C). Two independent babo RNAi lines were
Figure 1. Heart-specific knockdown of daw slows cardiac aging. (A) QRT-PCR analysis of daw expression in young and old fly hearts. N = 3. Student t-test (** p < 0.01). (B)
Representative M-mode traces (8 s) showing age-dependent movement of heart wall in control and heart-specific daw knockdown flies (Hand-gal4> UAS-dawRNAi). (C-F)
Age-related changes in arrhythmia index, diastolic intervals, heart period, and cardiac output in control (Ctrl) and cardiac-specific daw knockdown flies (dawRNAi). Flies were
cultured at 40% relative humidity. Hand-gal4 driver was used to knockdown gene expression specifically in cardiac tissues (cardiomyocytes and pericardial cells). Results
from three independent UAS-dawRNAi lines are shown (RNAi #1: BDSC, 34974, RNAi #2: Vienna Drosophila Resource Center, 105309, RNAi #3: BDSC, 50911). N = 7 ~ 20. Two-
way ANOVA followed by Tukey multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant). The interaction between genotype and age is
statistically significant for heart period (p = 0.0041) and diastolic interval (p = 0.0243). (G-I) Age-dependent changes in cardiac arrhythmia between control and daw
knockdown using various tissue drivers, Hand-gal4 (cardiomyocytes and pericardial cells), tinc-gal4 (cardiomyocytes), and Dot-gal4 (pericardial cells). N = 25 ~ 31. Student
t-test (* p < 0.05, ** p < 0.01, *** p < 0.001). (J) Age-dependent changes in diastolic intervals between control and daw knockdown in pericardial cells (Dot-gal4). N = 13 ~ 26.
Student t-test (* p < 0.05, ** p < 0.01, *** p < 0.001). (K) Immunostaining of p-Smox in fly hearts at young (2 weeks) and old ages (6 weeks). Arrows indicate cardiomyocyte
nuclei and positive p-Smox staining. Scale bar: 20 μm. Quantification shown on the right. N = 8. Student t-test (* p < 0.05). Data are represented as mean ± SEM in all figures.
(L) Age-dependent changes in arrhythmia index, diastolic intervals, heart period between control and Smox knockdown (tinc-gal4). N = 11 ~ 31. Student t-test (* p < 0.05).
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used and both gave similar results (the knockdown effi-
ciency of babo RNAi was verified by qRT-PCR in our
previous study [20]. Knockdown of babo did not affect age-
dependent changes in cardiac output (Figure S1L), which
may be attributed to the similar diastolic diameter and
systolic diameter between wild-type and babo knockdown
flies (Figure S1M,N). These results suggest that babo and
daw regulate both common and distinct aspects of cardiac
function.
In a reciprocal experiment, we used a GeneSwitch heart
driver (Hand-GS-gal4) to express a constitutively active
form of babo (baboAct, or baboQ302D) specifically in adult
hearts. GeneSwitch heart driver was used because constitu-
tively expressing active babo in the heart (Hand>baboAct)
led to severe developmental arrest at pupal stages (data not
shown). We found that cardiac expression of activated babo
significantly increased cardiac arrhythmia, diastolic inter-
vals, and heart period already at young ages (Figure 2D–F).
Taken together, these results suggest that INHB/activin
type I receptor babo plays an important role in age-
related cardiomyopathy, especially cardiac arrhythmia, dia-
stolic function, and heart rate.
daw negatively regulates autophagy in fly hearts
Autophagy is one of the key mechanisms in maintaining
tissue hemostasis, and its activity normally declines with age
[4,6,7]. Our previous studies showed that TGFB-INHB/activin
signaling regulates autophagosome formation and Atg8a tran-
scription in Drosophila flight muscle [20]. It is likely that daw
regulates cardiac aging by modulating autophagic activity. To
first verify the role of daw in autophagy-lysosome activity, we
used LysoTracker staining, a well-established autophagy mar-
ker in flies [24], to monitor the lysosomal acidification in
adult fat body. Consistent with our previous finding, hetero-
zygous daw[11] loss-of-function mutants showed increased
LysoTracker staining, suggesting an elevated basal autop-
hagy/lysosome activity (Figure 3A). We furthermore showed
that mutation of daw increased autophagic flux, indicated
by the induction of lipidated Atg8a (Atg8a-II) upon the
treatment of lysosome inhibitor bafilomycin A1 (BafA1)
(Figure 3B). Atg8a is the fly homolog of mammalian LC3-
GABARAP family proteins. A rabbit monoclonal antibody for
human GABARAP (E1J4E) [25–27] was used in the lipidation
assay. The specificity of the antibody has been previously
Figure 2. Cardiomyocyte-specific knockdown of INHB/activin receptor babo delays cardiac aging. (A-C) Age-dependent changes in cardiac arrhythmia, diastolic
intervals, and heart period in control (Ctrl) and cardiomyocyte-specific babo knockdown flies (babo RNAi). Flies were cultured at 40% relative humidity. tinc-gal4 driver
was used. Results from two independent UAS-baboRNAi lines are shown (RNAi #1: BDSC, 25933, RNAi #2: BDSC, 40866). N = 15 ~ 30. One-way ANOVA (*** p < 0.001,
** p < 0.01, * p < 0.05, ns = not significant). (D-F) Changes in cardiac arrhythmia, diastolic intervals, and heart period in fly hearts expressing constitutively activated
babo (baboAct). GeneSwitch heart driver Hand-GS-gal4 was used to induce adult-onset babo activation. RU: RU486 (Mifepristone). Flies were cultured at 40% relative
humidity. N = 6 ~ 9. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant).
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verified [28] and further confirmed in the present study
(Figure S2, also see Methods). Finally, the mosaic analysis
revealed that somatic cell clones in larval fat body expressing
RNAi against either daw or babo (marked by GFP) showed
increased numbers of autophagosome, indicated by mCherry-
Atg8a-positive puncta (Figure 3C). These data suggest that
TGFB-INHB/activin signaling negatively regulates autophagy
and lysosome activities.
Figure 3. Daw negatively regulates autophagy in fly hearts. (A) Representative images of LysoTracker staining of young adult fat body between wild-type (WT) and
heterozygous daw[11]/+ mutants. Scale bar: 20 μm. Quantification shown on the right. N = 5. Student t-test (*** p < 0.001). (B) Western blot analysis on Atg8a lipidation
betweenWT and daw[11]/+mutants. GABARAP antibodies were used to detect Atg8a. The lower band represents lipidated Atg8a (Atg8a-II), and the upper band represents
non-lipidated Atg8a (Atg8a-I). Abdominal fly carcass is incubated with 5 μMof BafA1 prior to western blots. ACTB (actin beta) is used as the loading control. Quantification of
band intensity shown on the right. N = 3. Student t-test (*** p < 0.001). (C) Representative images of mosaic analysis on autophagosome staining in larval fat body. Fat body
clones were generated by crossing dawRNAi and baboRNAi lines into a FLPout line carrying mCherry-Atg8a reporter (hs-flp; endogenous P-3xmCherry-Atg8a, UAS-GFP/Cyo;
Act>CD2> Gal4,UAS-Dcr-2). RNAi Clones are GFP-positive cells (dashed lines). Scale bar: 20 μm. Quantification of autophagosome puncta shown on the right. N = 5. Student
t-test (** p < 0.01). (D) Representative images of fly hearts expressing autophagosome reporter mCherry-Atg8a at both young and old ages. Arrows indicate cardiomyocyte
nuclei and surrounding autophagosomes. Abdominal segments A2-A3 are shown. Heart tube is located between two yellow dashed lines. (E-G) Representative images of
mCherry-Atg8a reporter surrounding cardiomyocyte nuclei in control, dawRNAi, and baboAct flies with or without BafA1 treatment. Semi-intact hearts were incubated with
100 nM of bafilomycin A1 (BafA1) for 2 h prior to immunostaining. Scale bar: 10 μm. (H) Quantification of age-dependent changes in autophagic flux in control, daw
RNAi, and
baboAct fly hearts. tinc-gal4 was used to drive the expression of mCherry-Atg8a reporter and gene knockdown. N = 5 ~ 7. One-way ANOVA (*** p < 0.001, ** p < 0.01,
* p < 0.05, ns = not significant). (I) Quantification of age-dependent changes in autophagic flux in control and dawRNAi fly hearts. Hand -gal4was used to drive the expression
of mCherry-Atg8a reporter and daw knockdown. N = 5 ~ 7. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (J) Quantification of BafA1-induced
mCherry-Atg8a-positive puncta between control and dawRNAi. The data represent the differences in the number of puncta between BafA1 and DMSO treatments.
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Next, we examined whether daw plays a similar role in
modulating autophagy in fly hearts. Immunostaining with
GABARAP (E1J4E) antibodies showed that the number of
autophagosome in the heart was higher in daw[11] mutants
compared to wild-type (Figure S3A,B). Because autophagy is
a dynamic process, the increased number of autophagosome
could result from elevated autophagy activities, or blockage of
lysosomal degradation [29]. To test these possibilities, we next
examined the role of daw in the regulation of autophagic flux
(the turnover of autophagosome). We exposed semi-intact fly
hearts to BafA1, the V-ATPase inhibitor that blocks both
lysosomal acidification and autophagosome-lysosome fusion
[30]. We found that BafA1 treatment resulted in a higher
induction in the number of Atg8a-positive autophagosome in
daw[11] hearts compared to wild-type hearts (Figure S3A–C).
Thus, the results suggest that daw negatively regulates autop-
hagic flux in fly hearts.
Knockdown of daw preserves autophagic activity during
cardiac aging
Aging tissues show reduced autophagy and accumulated cel-
lular damages. We next examined whether inhibition of
INHB/activin-daw signaling in fly hearts can alleviate age-
dependent deregulation of autophagy. Using a mCherry-
Atg8a reporter line, we observed a large accumulation of
Atg8a-positive autophagosome in aged hearts of wild-type
flies (Figure 3D,E,H,I). The age-related accumulation of
autophagosome was not due to increased expression of the
cardiac driver. Because both Hand-gal4 and tinc-gal4 drivers
showed either reduced or no change of expression during
aging (Figure S1A,B). In fact, the accumulation of autophago-
some is likely due to the blockage of autophagosome turnover
(autophagic flux), because BafA1 treatment induced Atg8a-
positive puncta in young hearts, but not in the old hearts
(Figure 3E,H,I,J). To confirm this finding, we monitored
autophagosome using an alternative method, the immunos-
taining with GABARAP antibody (Figure S4A,B). We
observed a similar accumulation of autophagosome in aged
hearts, and the autophagic flux was also reduced during aging
(Figure S4A,B). Furthermore, we found that the receptor
protein ref(2)P/SQSTM1/p62, a marker for defective aggre-
phagy [31], was accumulated in aging hearts and Atg8a
mutants (Figure S5), suggesting an age-related impairment
in autophagy/lysosome degradation system. We also tested
autophagic flux using mCherry-GFP-Atg8a tandem reporter.
However, we hardly observed any GFP signals in fly hearts,
even after BafA1 treatment (Figure S4C). This is quite differ-
ent from fat body tissue, where BafA1 treatment significantly
induced GFP signals when the tandem reporter was expressed
using r4-gal4 (Figure S4D).
Intriguingly, flies with heart-specific daw knockdown
maintained high levels of cardiac autophagosome turnover
(or active autophagic flux) at both young and old ages, as
indicated by the induction of autophagosome number upon
BafA1 treatment (Figure 3F,H,I,J). Notably, constitutively
activated babo suppressed the autophagic flux in both young
and old hearts (Figure 3G,H). Activation of babo also blocked
the age-dependent accumulation of autophagosome in old fly
hearts (Figure 3G,H), which suggests that besides the regula-
tion of autophagosome turnover (degradation), TGFB-INHB
/activin signaling also plays an important role in autophago-
some initiation and formation. Taken together, our findings
suggest that reduction of INHB/activin-daw signaling pro-
motes autophagosome turnover and preserves autophagic
activity during cardiac aging.
Inhibition of autophagy, but not activation of TORC1,
blocks daw knockdown-mediated cardioprotection
Since we observed an induction of autophagy in daw knock-
down flies, we next asked whether autophagy activity is
required for daw-regulated cardiac aging. First, we fed control
and daw knockdown flies with a lysosomal inhibitor chloro-
quine (CQ). As expected, CQ treatment increased cardiac
arrhythmia in daw knockdown flies back to the similar levels
seen in old wild-type flies (Figure 4A), while CQ treatment is
nontoxic and did not lead to any mortality within two weeks
of feeding (Figure S5D). To directly test whether autophagy
plays any role in daw-regulated cardiac aging, we generated
double knockdown flies by combining UAS-daw RNAi and
UAS-Atg1 RNAi fly lines. Atg1 is a serine/threonine-protein
kinase that is essential for autophagy initiation, and has been
previously shown to play a role in regulating cardiac function
[32]. Cardiac-specific knockdown of Atg1 increased both car-
diac arrhythmia and diastolic intervals at young and old ages
(Figure 4B), similar to the fly heart with activated babo
(Figure 2D,E). Consistent with CQ treatment, cardiac-
specific knockdown of Atg1 attenuated cardioprotective
effects of daw RNAi. Simultaneously knockdown of Atg1
and daw in the heart led to an age-dependent increase in
arrhythmia similar to control flies (Figure 4C). Atg1 knock-
down in daw RNAi background also slightly increased
arrhythmia at young ages (Figure 4C). The knockdown effi-
ciency of daw was not affected by combining daw RNAi and
Atg1 RNAi lines (Figure S5E). Thus, these results suggest that
autophagic activity and Atg1 are required for daw-regulated
cardiac aging.
TORC1 is a key negative regulator of autophagy (Figure S6A)
[24]. We found that TORC1 activity, indicated by phosphoryla-
tion of Thor/EIF4EBP1, was reduced in daw knockdown flies
(Figure S6B). We then tested whether daw could regulate autop-
hagy and cardiac aging through TORC1 signaling. If TORC1 acts
as a downstream effector of daw to regulate autophagy and
cardiac aging, one would expect that activation of TORC1 can
attenuate daw knockdown-mediated cardiac protection and
autophagy induction. To test this possibility, we first generated
double knockdown flies by combiningUAS-daw RNAi andUAS-
Tsc1 RNAi. Drosophila Tsc1 (TSC complex subunit 1) is
a negative regulator of TORC1, knockdown of Tsc1 increased
the phosphorylation of Thor/EIF4EBP1 in fly hearts (Figure S6B).
The knockdown efficiency of Tsc1 is shown in Figure S6C.
Surprisingly, activation of TORC1 via Tsc1 knockdown had no
effects on cardiac arrhythmia (Figure 4D), but reduced diastolic
intervals at young age (Figure 4E), which is very different from
the cardiomyopathy resulted from cardiac-specific activation of
INHB/activin receptor babo (Figure 2D,E). Furthermore, knock-
down of Tsc1 did not affect the cardioprotective role of daw
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silencing (Figure 4F). Simultaneously knockdown of Tsc1 and
daw showed similar arrhythmia index as daw RNAi alone. In
addition, loss-of-function mutant Tsc1[12] did not rescue the
elevated LysoTracker staining in daw[11] mutants (Figure 4G).
These results suggest that activation of TORC1 is not required for
daw-regulated autophagy and cardiac aging.
It is known that inhibition of TORC1 prolongs lifespan
[15,33] and attenuates stress-induced cardiomyopathies
[11,34–36]. However, the specific role of TORC1 in cardiac
aging is not well understood. Here, we observed unique alter-
nations of cardiac function in response to activation of TORC1
(via Tsc1 knockdown), including decreased heart period
(Tachycardia, fast heart rate), and reduced diastolic intervals
(Figures 4E, S6D,E) These cardiac functional changes are not
the same as age-induced cardiomyopathies, rather they resem-
ble high-fat-diet-induced cardiac complications where TORC1
is known to play an important role [12]. Intriguingly, flies with
cardiac-specific knockdown of Tsc1 showed no age-dependent
increases in heart period, diastolic intervals, and arrhythmia
(Figure S6D–F). Similar cardiomyopathy phenotypes were also
observed in other TORC1 activation mutants, such as 1)
knockdown of REPTOR (Repressed by TOR), a recently iden-
tified bZIP transcription factor that is negatively regulated by
TORC1 [37] (Figure S6G–I), and 2) overexpression of Rheb
(Ras Homolog Enriched in Brain), a positive regulator of
TORC1 (Figure S6J–L). Thus, it seems that INHB/activin-daw
signaling and TORC1 exhibit different effects on cardiac
function.
daw genetically interacts with TORC2 (rictor) to control
autophagy and cardiac aging
Besides the regulation of p-Thor (Figure S6B), cardiac-
specific knockdown of daw increased the phosphorylation of
Figure 4. Inhibition of autophagy, but not activation of TORC1, blocks daw knockdown-mediated cardioprotection. (A) Cardiac arrhythmia of chloroquine-
treated (20 mM, 24 h) 6-week-old control and daw knockdown flies (Hand-gal4 used). N = 14 ~ 38. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05,
ns = not significant). (B) Cardiac diastolic intervals and arrhythmia in heart-specific knockdown of Atg1 at young and old ages (Hand-gal4 used).
N = 16 ~ 19. One-way ANOVA (*** p < 0.001, * p < 0.05). (C) Age-dependent changes in cardiac arrhythmia in control, dawRNAi, and dawRNAi; Atg1RNAi
flies (tinc-gal4 used). N = 16 ~ 35. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (D-E) Cardiac arrhythmia and diastolic
intervals of Tsc1 knockdown flies (tinc-gal4 used). Two independent Tsc1 RNAi lines were used (RNAi-1: BDSC, 52931, RNAi-2: BDSC, 54034). N = 16 ~ 18.
One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (F) Age-dependent changes in cardiac arrhythmia in control, dawRNAi, and
dawRNAi; Tsc1RNAi flies (tinc-gal4 used). N = 7 ~ 30. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (G) Representative images
of LysoTracker staining in adult fat body of WT, daw[11]/+, Tsc1[12]/+ and double mutants daw[11]/+; Tsc1[12]/+. Scale bar: 10 μm. Quantification shown on
the right. N = 5. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant).
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Akt1 (at Ser505) in the heart, the upstream regulator of
TORC1 (Figure 5A). On the other hand, activated receptor
babo decreased cardiac Akt1 phosphorylation (Figure 5B). It
is interesting that the p-Akt1 appeared as fluorescence puncta
in fly hearts. The p-Akt1 puncta might be associated with
mitochondria, since it has been shown that MTORC2 and
Akt1 are localized on mitochondria-associated endoplasmic
reticulum (ER) membrane [38]. We further confirmed the
regulation of Akt1 phosphorylation by TGFB-INHB/activin
signaling using immunoblotting (Figure 5C). Although the
activation of babo did not alter Akt1 phosphorylation in
western blotting analysis, we think that the lack of changes
in Akt1 phosphorylation might be due to the contamination
of adjacent tissue (e.g., fat body). It is known that Akt1 can be
activated and phosphorylated by two kinases at distinct posi-
tions, PDPK1/Pdk1 (3-phosphoinositide dependent protein
kinase 1) at Thr308 and MTORC2 at Ser473 (Ser505 in
flies) [39]. Cardiac-specific overexpressing rictor can also
induced Akt1 phosphorylation (Figure 5D). Interestingly,
knockdown of daw and babo upregulated the mRNA expres-
sion of rictor in fly hearts (Figure 5E). These results suggest
that INHB/activin-daw is a negative regulator of MTORC2
(rictor).
Unlike TORC1, the role of TORC2 in the regulation of
autophagy is unclear. Intriguingly, we found that loss-of-
function mutants rictor[42] suppressed the high lysosomal
activities in daw[11] mutants (Figure 5F,G). Similarly, muta-
tions in Sin1, another core component of TORC2, blocked
the elevated LysoTracker staining in daw mutants (Figure
S7A,B). Cardiac-specific knockdown of either rictor or Akt1
attenuated the induction of autophagosome formation by
daw RNAi in fly hearts (Figure 5H). Furthermore, the
mosaic analysis revealed that overexpression of rictor
induced lysosome activity (Figure 5I) and increased the
number of Atg8a-positive autophagosome in fat body
(Figure 5J). Interestingly, unlike Tsc1 mutants, rictor[42]
did not suppress starvation-induced LysoTracker staining
(Figure S7C). Similarly, activated TGFB/activin signaling
(baboAct) did not block starvation-induced lysosome activ-
ity (Figure S7D). Taken together, these data suggest that
TGFB-INHB/activin signaling and TORC2 (rictor) regulate
autophagy differently from TORC1, and rictor acts down-
stream of TGFB-INHB/activin signaling in the regulation of
autophagy.
Lastly, we noticed that the levels of p-Akt1 decreased
in aging hearts (Figure 6A), while overexpression of rictor
induced autophagic flux in old fly hearts (Figure 6B). Given
that rictor positively regulates autophagy, we predict that
rictor is a cardiac protective factor. Indeed, cardiac-specific
overexpression of rictor prevented age-related increases in
diastolic intervals and arrhythmia (Figure 6C,D), while
knockdown of rictor induced arrhythmia, especially at old
ages (Figure 6E). Knockdown of rictor also attenuated the
cardioprotection by daw RNAi (Figure 6F). Furthermore,
overexpression of rictor attenuated the elevated diastolic
intervals and arrhythmia in fly hearts with constitutively
activated babo (Figure 6G–I), suggesting that fly TGFB/
activin signaling regulates cardiac aging through TORC2
(rictor) (Figure 6J).
Cardiac-specific reduction of INHB/activin-daw and
overexpression of rictor prolong lifespan
Tissue-specific hormonal signaling in systemic aging control
has been previously reported [40–42]. However, whether pro-
longed organismal lifespan can be achieved by maintaining
healthy hearts remains less clear. Here we tested the effects of
cardiac-specific knockdown of INHB/activin signaling in
longevity control. Knockdown of daw in the heart using two
cardiac tissue drivers (tinc-gal4 and Hand-gal4) significantly
prolongs lifespan (36.2% and 23.2% extension of mean life-
span compared to control lines) (Figure 7A,B,D). Because daw
is a hormonal factor, it remains to be determined whether
daw regulates lifespan through cell-autonomous or non-
autonomous mechanisms. Interestingly, cardiac-specific over-
expression of rictor also extended lifespan (12% extension of
mean lifespan) (Figure 7C,D). Together, our findings suggest
that cardiac-specific INHB/activin-daw and TORC2 (rictor)
signaling pathways play important roles in regulating autop-
hagy, cardiac health, as well as longevity.
Discussion
TGFB signaling plays vital roles in a wide range of human
diseases, including cancer and cardiovascular diseases [43].
Originally identified as a reproductive hormone, INHB/acti-
vin, a TGFB subfamily member, has become an emerging
target for the treatment of many human diseases [44]. In the
present study, we discover a novel crosstalk between TGFB-
INHB/activin and TORC2 in the regulation of autophagy and
cardiac aging in Drosophila. Similar to our previous study in
Drosophila flight muscle [20], reduction of TGFB-INHB/acti-
vin signaling alleviates age-related cardiac dysfunction, mainly
through the regulation of cardiac autophagic activity. Mutant
daw flies exhibit high autophagic flux and elevated lysosome
activities. Importantly, we show that activation of TORC1
does not block daw knockdown-mediated cardioprotective
effects. Instead, INHB/activin-daw signaling interacts with
TORC2 subunit rictor to regulate autophagy and cardiac
function. Activation of TORC2 alone can promote cardiac
autophagy and maintain cardiac function at old ages. Taken
together, our studies identify TGFB-INHB/activin signaling as
a novel upstream regulator of TORC2, and INHB/activin-
mediate inhibition of TORC2 might be a novel mechanism
for age-related autophagy impairment and cardiomyopathy.
Although previous studies have linked TGFB family proteins
to longevity regulation [20,21,45], the role of TGFB-INHB/acti-
vin signaling in cardiac aging is still not well understood. It has
been shown that INHBA/ACTIVIN A serum levels significantly
increase with age [46]. The mRNA expression of INHBA/
ACTIVIN A, as well as serum INHBA/ACTIVIN A levels are
positively correlated with heart failure [47,48], and hypertension
in the elderly [49]. These findings suggest that activation of
TGFB-INHB/activin signaling at old ages might be detrimental
to the heart. It is known that INHBA/ACTIVIN A promotes
cardiac fibrosis and myocardial damage after ischemia reperfu-
sion [50]. Consistently, mice with heterozygous mutations of
ACVR1B/ALK4 are protected from pressure overload-induced
fibrosis and dysfunction [51,52]. Inhibition of TGFBR1/ALK5
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Figure 5. Dawgenetically interactswith TORC2 (rictor) to control autophagy. (A) Representative images of p-Akt1 staining in cardiomyocytes of control and daw knockdown flies
(Hand-gal4). Scale bar: 10 μm. Quantification shown on the right. N = 5. Student t-test (* p < 0.05). (B) Representative images of p-Akt1 staining in cardiomyocytes of control and
babo-activated flies (Hand-gal4). Scale bar: 10 μm.Quantification shownon the right. N= 5. Student t-test (*** p< 0.001). (C)Western blot analysis onAkt1 phosphorylation of the
hearts dissected from control, daw knockdown and babo-activated flies (Hand-gal4). Quantification of band intensity shown on the right. N = 3. Student t-test. (D) Representative
images of p-Akt1 staining in cardiomyocytes of control and rictor overexpression (Hand-gal4). Two independent rictor overexpression used (#1: UAS-rictor, #2: UAS-HA-rictor [72]).
Scale bar: 10 μm. Quantification shown on the right. N = 5. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (E) QRT-PCR analysis of rictor expression in
fly hearts with daw and babo knockdown (Hand-gal4). N = 3. Student t-test (* p < 0.05). (F) Representative images of LysoTracker staining in adult fat body of WT, daw[11]/+,
rictor[42]/+ and double mutants rictor[42]/+; daw[11]/+. Scale bar: 20 μm. Quantification shown on the right. N = 5. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not
significant). (G) Representative images of Magic Red staining in adult fat body of WT, daw[11]/+, rictor[42]/+ and double mutants rictor[42]/+; daw[11]/+. Scale bar: 20 μm.
Quantification shown on the right. N = 5. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (H) Representative images of GABARAP immunostaining in
cardiomyocytes of BafA1-treated control, dawRNAi alone, dawRNAi; rictorRNAi, and dawRNAi; Akt1RNAi flies. Scale bar: 20 μm. Quantification shown on the right. N = 15. Student t-test
(*** p < 0.001). (I) Representative images of mosaic analysis of LysoTracker staining in larval fat body. Fat body clones were generated by crossing rictor overexpression lines into
a FLPout line (yw, hs-flp, UAS-CD8::GFP; Act>y+>Gal4,UAS-GFP.nls;UAS-Dcr-2). Clones with rictor overexpression are GFP-positive cells (dashed lines). Scale bar: 20 μm. (J)
Representative images of mosaic analysis of autophagosome staining in larval fat body. Fat body clones were generated by crossing rictor overexpression lines into a FLPout line
carrying mCherry-Atg8a reporter (hs-flp; endogenous P-3x mCherry-Atg8a, UAS-GFP/Cyo; Act>CD2> Gal4,UAS-Dcr-2). Clones with rictor overexpression are GFP-positive cells
(dashed lines). Scale bar: 20 μm.
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also reduces myocardial infarction-induced systolic dysfunction
and left ventricular remodeling in rats [53]. However, other
studies suggest that INHBA/ACTIVIN A protects hearts from
hypoxia/reoxygenation- and ischemia/reperfusion-induced cell
death [54], even though it can promote cardiac apoptosis at
higher concentrations [55]. The findings from our study support
the detrimental effects of TGFB-INHB/activin signaling in car-
diac function at old ages. This is consistent with the pro-aging
action of TGFB and INHB/activin [20,45]. In addition, our
results also suggest that daw-regulated cardiac aging through
a Smox/SMAD2-independent pathway (Figure 1).
TGFB-INHB/activin signaling has been implicated in the
regulation of a wide range of cellular processes, including cell
death and proliferation, inflammation, fibrosis, and metabolic
homeostasis [44,56–58]. The role of TGFB-INHB/activin sig-
naling in the control of autophagy, a key tissue maintenance
process, has only been carefully characterized recently
[20,59,60]. In Caenorhabditis elegans, the reduction of
INHB/activin-like protein DAF-7 suppresses beta-amyloid
peptide-induced autophagosome accumulation [59]. Another
recent study found that INHBA/ACTIVIN A blocked oxygen-
glucose deprivation-induced autophagy through the inhibi-
tion of MAPK8/JNK and MAPK14/p38 MAPK pathways in
neuronal PC12 cells [60]. Our previous studies show that
knockdown of Drosophila INHB/activin-like protein daw in
flight muscle induces autophagosome formation and autop-
hagy gene expression [20]. However, how TGFB-INHB/acti-
vin signaling regulates autophagy and how this regulation
contributes to tissue homeostasis during aging remain largely
unknown. Our findings suggest that fly INHB/activin-like
protein daw promotes cardiac aging through inhibition of
autophagy and TORC2 signaling. Importantly, fly hearts
with reduced daw expression maintain high levels of autop-
hagosome turnover (or autophagic flux) throughout the life,
whereas the autophagosome turnover is largely blocked in
aged hearts of wild-type flies. The active autophagosome turn-
over at old ages is likely responsible for the healthy hearts seen
in daw knockdown flies. Intriguingly, TORC2 but not TORC1
is required for daw-regulated cardiac autophagy. These find-
ings reveal a novel mechanism for age-dependent autophagy
Figure 6. Heart-specific overexpression of rictor preserved cardiac function during aging. (A) Representative images of p-Akt1 staining in young and old cardiomyocytes of wild-
type flies. Scale bar: 10 μm. Quantification shown on the right. N = 12. Student t-test (** p < 0.01). (B) Representative images of autophagic flux in control and rictor
overexpressing cardiomyocytes at old ages (Hand-gal4). Scale bar: 10 μm. Quantification shown on the right. N = 15. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05,
ns = not significant). (C-D) Diastolic intervals and arrhythmia index in flies with heart-specific overexpression of rictor (Hand-gal4). N = 19 ~ 26. One-way ANOVA (*** p < 0.001,
** p < 0.01, * p < 0.05, ns = not significant). (E) Cardiac arrhythmia index in flies with heart-specific knockdown of rictor. N = 24. One-way ANOVA (*** p < 0.001, ** p < 0.01,
* p < 0.05, ns = not significant). (F) Cardiac arrhythmia index in flies with heart-specific knockdown of daw alone or daw; rictor double knockdown. N = 15 ~ 30. Student t-test
(*** p < 0.001, * p < 0.05, ns = not significant). (G-I) Diastolic intervals, arrhythmia index, and heart period in flies with heart-specific expression of baboAct, or baboAct; rictorOE
(Hand-gal4). N = 11 ~ 27. One-way ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant). (J) Proposed model: INHB/activin-mediated inhibition of MTORC2 as
a novel mechanism for age-dependent regulation of autophagy and cardiac health.
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regulation that is mediated through the interplay between
INHB/activin and TORC2. On the other hand, our results
further suggest that TGFB-INHB/activin acts as a key
upstream regulator of TORC2 signaling.
TheMTOR signaling, in particular, MTORC1, is a well-known
autophagy regulator and it inhibits autophagosome formation by
increasing the phosphorylation of the serine/threonine protein
kinaseAtg1 (ULK1/ULK2 inmammals), the initiator of the autop-
hagy machinery [5]. Intriguingly, activation of TORC1 does not
block the induction of autophagosome formation in daw knock-
down flies, suggesting that there might be unknown TORC1-
independent mechanisms involved in daw-regulated autophagy
and cardiac aging. TORC1-independent autophagy regulation has
been observed in several recent studies [61–63]. A genome-wide
screen study identifies an important role of class III phosphatidy-
linositol 3-kinase in autophagy control under normal nutritional
conditions [61]. The screen also revealed that growth factor signal-
ing pathways, such as MAPK/ERK and AKT-FOXO3, negatively
regulate autophagy by inhibiting the class III phosphatidylinositol
3-kinase cascade. Interestingly, we show that knockdown of daw
leads to elevated Akt1 phosphorylation and increased expression
of TORC2 subunit rictor, suggesting TORC2-AKT signaling may
be involved in daw-regulated autophagy and cardiac aging.
Indeed, mutation of rictor blocks the activation of autophagy in
daw knockdown flies. MTORC2 is one of the two MTOR com-
plexes that is insensitive to short-term rapamycin treatment, and is
involved in glucose homeostasis and actin cytoskeleton reorgani-
zation [64,65]. The direct regulatory role of MTORC2 (RICTOR)
in autophagy has not been previously established, although several
studies suggest that mammalian RICTOR may be involved in
autophagy activation under certain circumstances. For example,
RICTOR is required for resveratrol-induced autophagy in rat
myocardium and H9c2 cardiac myoblast cells [66]. In rat kidney
NRK-52E cells, silencing Rictor blocks cisplatin-induced autop-
hagy [67]. Our findings align with these studies suggesting that
Drosophila rictor is a positive regulator of autophagy. However,
conflicting findings are reported in other studies showing
RICTOR negatively regulates autophagosome formation in
mouse skeletal muscle [68], and LC3-II levels in human senescent
endothelial cells [69]. Together, our results suggest thatDrosophila
TORC2 (rictor) is a positive regulator of autophagy, which is
opposite to what TORC1 does. The distinct regulation of autop-
hagy by 2 MTOR complexes may explain why MTORC1 and
MTORC2 differentially control lifespan.
The positive regulation of autophagy by rictor identified in
the present study suggests that activation of TORC2 may be
cardioprotective. Indeed, we show that cardiac-specific overex-
pression of rictor slows cardiac aging, similar to daw knock-
down. These findings are consistent with two recent studies
showing that disruption of mammalian RICTOR induces cardiac
dysfunction [13,14]. Cardiac-specific deletion of Rictor in mice
induces dilation and decreases fractional shortening by activating
MST1 kinase and hippo pathway [14]. Deletion of Rictor
decreases lifespan in male mice [16], although conflicting results
are reported in C. elegans [70,71]. Interestingly, we show that
cardiac-specific overexpression of rictor prolongs Drosophila life-
span, which is consistent with shortened lifespan seen in rictor
deletion mice [16]. Besides longevity regulation, it has been
shown that Drosophila mutants of rictor and Sin1 decrease the
tolerance to heat stress [72] and overexpression of rictor rescues
Pink1 knockdown-induced mitochondrial aggregation in
Drosophila indirect flight muscle [73]. Conversely, overexpres-
sion of PINK1 increases AKT phosphorylation in human SH-
SY5Y neuroblastoma cells [74]. The rictor-Pink1 interaction
suggests that rictor could be a potential positive regulator for
mitophagy, a key process for the mitochondria quality control
Figure 7. Cardiac-specific knockdown of daw and overexpression of rictor prolong lifespan. (A-B) Survival analysis of cardiac-specific (tinc-gal4 and Hand-gal4)
knockdown of daw. Two control lines used (yw and mCherry RNAi) were performed. Log-Rank test, p < 0.0001. (C) Survival analysis of heart-specific (Hand-gal4)
overexpression of rictor. Log-Rank test, p = 0.0005. (D) Lifespan table to show sample size, mean and median lifespan of the survival analysis.
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during aging. Interestingly, we found that p-Akt1 exhibits
a puncta pattern in fly hearts. We speculate that the p-Akt1
puncta may be associated with mitochondria and ER subcom-
partment, since it has been shown that MTORC2 (RICTOR) is
localized at the mitochondria-associated ER membrane [38].
Future work is needed to examine whether and how TORC2
(rictor) regulates mitophagy activity to maintain mitochondrial
quality in the heart.
Different from TORC2, TORC1 is known to promote age-
dependent increases in cardiac dysfunction in Drosophila
[11,36]. Cardiac-specific overexpression of TORC1 increases
stress-induced heart failure, whereas overexpression of Tsc1
and Tsc2 prevents the age-related increase of stress-induced
heart failure [11]. Interestingly, we show that activation of
TORC1 produced unique cardiac changes that are different
from aging fly hearts. Cardiac-specific activation of TORC1
via knockdown of Tsc1 induced heart rate and decreased heart
period, which is similar to cardiac dysfunction caused by
high-fat-diet feeding [12]. A recent study found that
MTORC1 activity does not increase with age in most tissues
of wild-type mice, arguing that the assumption about
increased MTOR signaling driving age-related pathology
may be overly simplified [75]. Intriguingly, cardioprotective
effects of MTOR were previously observed in a mouse model
with cardiac-specific overexpression of MTOR (MTOR-Tg)
[76]. The MTOR-Tg mice show attenuated inflammatory
response and cardiomyopathy upon left ventricular pressure
overload induced by transverse aortic constriction. It is
unclear whether MTOR-Tg affects only MTORC1 or both
MTOR complexes. Thus, the distinct role of MTORC1 and
MTORC2 in stress- and aging-induced cardiac dysfunction
remains to be further examined.
During normal aging, the heart undergoes complex phe-
notypic changes such as progressive myocardial remodeling,
reduced myocardial contractile capacity, increased left ven-
tricular wall thickness and chamber size, prolonged diastole
as well as increased arrhythmia [3]. All of these biological
changes can gradually alter cardiac functions and confer
vulnerability of the heart to various cardiovascular stresses,
thus increasing the chance of developing cardiovascular dis-
ease dramatically. The present study reveals an important
role of TGFB-INHB/activin signaling pathway in the regula-
tion of autophagy and cardiac aging in Drosophila. We also
find an intriguing interaction between INHB/activin and
TORC2 in the regulation of cardiac autophagy, as well as
a new role of rictor in cardiac aging and longevity control in
Drosophila. It remains to be determined how INHB/activin
regulates TORC2 (rictor) in fly hearts. It is possible that
TGFB-INHB/activin signaling regulates rictor through both
transcriptional activation (e.g., INS-FOXO signaling [77])
and post-translational modification. Additionally, cardiac-
specific daw knockdown and rictor overexpression extend
fly lifespan, suggesting that longevity can be achieved by
maintaining a healthy heart. Our findings also suggest that
daw itself or other unidentified hormonal factors secreted
from cardiomyocytes may play an important role in systemic
aging control. Hence, it remains to be determined the
mechanistic basis for INHB/activin-TORC2-mediated con-
trol of cardiac aging and longevity, which will eventually
help the development of therapeutic interventions targeting
INHB/activin and TORC2 for the treatment of age-related
cardiovascular diseases.
Materials and methods
Fly husbandry and stocks
Flies were maintained at 25°C, 60% relative humidity and 12 h
light/dark (40% relative humidity was used in the experiments
from Figures 1 and 2, which were performed in Bodmer labora-
tory). Adults were reared on agar-based diet with 0.8% cornmeal,
10% sugar, and 2.5% yeast (unless otherwise noted). Fly stocks
used in the present study are: UAS-daw RNAi (Bloomington
Drosophila Stock Center [BDSC], 34974, BDSC, 50911, and
Vienna Drosophila Resource Center [105309]), UAS-daw
(dawOE, Gift from Michael O’Connor, University of Minnesota
Twin Cities), UAS-Smox RNAi (BDSC, 26756), UAS-babo RNAi
(BDSC, 25933, 40866), UAS-baboAct/baboQ302D [78], UAS-Tsc1
RNAi (BDSC, 52931, 54034), UAS-REPTOR RNAi (BDSC,
25983), UAS-Rheb (BDSC, 9688), UAS-Atg1 RNAi (BDSC,
26731), UAS-rictor RNAi (BDSC, 36699), daw[11] [79], Tsc1[12]
[80], rictor[42] [81], Sin1[e03756] (BDSC, 18188), UAS-rictor [72],
UAS-HA-rictor [72], UAS-Akt1 RNAi (BDSC, 31701), Hand/
Hand4.2-gal4 [82], and tinc/tincΔ4-gal4 [83], Ugt36A1/Dot-gal4
[84], Hand-GS-gal4 [85], UAS-mCherry-Atg8a (BDSC, 37750),
Atg8aΔ4 [86], UAS-GFP.nls (BDSC, 4775), fln/IFM-gal4, da-GS-
gal4 [87], UAS-mCherry-GFP-Atg8a (Gift from Gábor Juhász,
Eotvos Lorand University, r4-gal4 (Gift fromMarc Tatar, Brown
University).
UAS-daw RNAi (BDSC, 34974) andUAS-babo RNAi (BDSC,
25933) were backcrossed into ywR background for 5 ~ 7 genera-
tions, and ywR flies were used as control or wild-type (WT) flies
in most of the experiments. For other UAS-RNAi lines that were
not backcrossed to ywR, following genotypes were used as con-
trol: y1 sc* v1; P[VALIUM20-mCherry]attP2 (BDSC, 35785), y1
v1; P[CaryP]attP2 (BDSC, 36303), or y1 v1; P[CaryP]attP40
(BDSC, 36304). Female flies were used in all experiments.
RU486 (Mifepristone; Cayman Chemical, 84371-65-3) were
used to activate Hand-GS-Gal4 at a final concentration of
200 µM mixed in food.
Mosaic analysis
Two FLPout lines were used: 1). hs-flp; endogenous P-3x
mCherry-Atg8a, UAS-GFP/Cyo; Act>CD2> Gal4,UAS-Dcr-2/
TM6) (kindly provided by Gábor Juhász, Eotvos Lorand
University). 2). yw, hs-flp, UAS-CD8::GFP; Act>y+>Gal4,UAS-
GFP.nls;UAS-Dcr-2/SM6::TM6B (kindly provided by Jun-yuan
Ji, Texas A&M University, originally generated by Bruce Edgar,
University of Utah). To generate clones, freshly laid eggs (within
4–6 h) were heated in a 37°C water bath for 45 min. Early L3
larvae (84 h after egg laying) were used in the experiments.
Fly heartbeat analysis
To measure cardiac function parameters, semi-intact Drosophila
adult fly hearts were prepared according to previously described
protocols [22]. High-speed 3000 frames movies were taken at
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a rate of 100 frames per second using a Hamamatsu ORCA-
Flash4.0 digital CMOS camera (Hamamatsu Photonics) on an
Olympus BX51WI microscope with a 10X water immersion lens.
Hamamatsu EM-CCD 9300 camera was used in the experiments
from Figures 1 and 2, which were performed in Bodmer labora-
tory. The live images that contain heart tub within abdominal
A3 segment were processed using HCI imaging software
(Hamamatsu Photonics). M-modes and cardiac parameters
were generated using SOHA, a MATLAB-based image applica-
tion as described previously [22]. The M-mode provides
a snapshot of the movement of heart wall over time. Cardiac
parameters were calculated as below: Diastolic interval (DI) is
the duration for each heart relaxation phase (diastole). Heart
period (HP) is the pause time between the two consecutive
diastoles (HP is the reciprocal of heart rate, HR). Systolic interval
(SI) was calculated as the HP minus the DI. Arrhythmia index
(AI) is the standard deviation of all HP in each fly normalized to
the median HP. Cardiac output was calculated using following
equation: (π r[d]2 – π r[s]2) x HR. r(d) is the radius of the heart
tube at diastolic phase, while r(s) is the radius of the heart tube at
systolic phase. Fractional shortening was calculated as (diastolic
diameters – systolic diameters)/diastolic diameters.
Quantitative RT-PCR
RNA extraction and cDNA synthesis were performed using
a Cells-to-CT kit (Thermo Fisher Scientific, 44-029-54) from
~15 dissected adult hearts. QRT-PCR was performed with
a Quantstudio 3 Real-Time PCR System (Thermo Fisher
Scientific). mRNA abundance of each gene was normalized
to the expression of RpL32 (Ribosomal protein L32) by the
method of comparative CT. Primer sequences are listed in
Table S1.
Antibodies and immunostaining
Since commercial antibodies for Drosophila Atg8a show nonspe-
cific staining in immunostaining of fly tissues (data not shown),
we used a human GABARAP (E1J4E) antibody (1:300) (Cell
Signaling Technology [CST], 13733) to stain and detect endogen-
ous Drosophila Atg8a. The epitope used to generate GABARAP
antibody has identical amino acid sequences to Drosophila Atg8a
protein (personal communication with Cell Signaling Technology
and see sequence alignment in Figure S2A). This antibody
has been previously used in several Drosophila autophagy studies
[25–27], and verified by Kim et al. [28]. We further verified the
specificity of the GABARAP antibody using an Atg8a loss-of-
function mutant Atg8aΔ4 (Figure S2B–D). Other antibodies used
for immunostaining are list below: ref(2)P (1:1000) (previously
generated by the Nezis laboratory) [31], p-Smox/SMAD2 anti-
body (1:500; CST, 3108), p-EIF4EBP1 (1:300; CST, 2855), p-AKT1
(Ser473, 1:300; CST, 4060), Alexa Fluor 488-conjugated phalloidin
(or Alexa Fluor 594) for F-actin staining (Thermo Fisher
Scientific, A12379, A12381). All fluorescence-conjugated second-
ary antibodies were from Jackson ImmunoResearch (Alexa Fluor
488, 711-545-152; Alexa Fluor 594, 711-585-152).
For immunostaining, adult female flies were collected and
dissected in PBS (Fisher Scientific, AAJ61196AP). Hearts were
fixed in 4% paraformaldehyde for 15 min at room temperature
(RT). After washing in PBS with 0.1% Triton X-100 (Fisher
Scientific, BP151-100) (PBST), the fixed hearted were blocked
in 5% normal goat serum (NGS; Jackson ImmunoResearch,
005-000-121) diluted in PBST for 1 h at RT. Hearts were
then washed with PBST and incubated overnight at 4°C with
primary antibodies diluted in 5% NGS. After washing with
PBST, the samples were incubated for 2 h at RT with appro-
priate fluorescence-conjugated secondary antibodies. Hearts
were mounted in ProLong Gold anti-fade reagent (Thermo
Fisher Scientific, P36930) before being imaged using an epi-
fluorescence-equipped Olympus BX51WI microscope.
Imaging analysis and quantification
For imaging analysis and quantification, fluorescence images
were first processed using the deconvolution module in
Olympus cellSens Dimensions software, and then the number
of puncta or fluorescent area/intensity in a selected region of
interest (ROI, ~707 µm2) surrounding cardiomyocyte nuclei
were measured with the “Measure and Count” module in
Olympus cellSens software. To quantify autophagosome in
fat body, the number of puncta per cell was measured. The
imaging quantifications were done single- or double-blind.
LysoTracker and Magic Red staining
Acidic organelles (including autolysosome) were monitored by
staining tissue with 100 nM LysoTracker Red DND-99 (Thermo
Fisher Scientific, L7528) for 5 min at room temperature.
Lysosomal CtsB1 (cathepsin B1) activities were monitored
using Magic Red Cathepsin-B Assay kit (ImmunoChemistry
Technologies, 938) following the manufacturer’s manual. Nuclei
were stained with either DAPI or Hoechst 33342 (1 µg/ml)
(ImmunoChemistry Technologies, 938).
Western blotting for Atg8a lipidation and Akt1
phosphorylation
Antibodies for western blot included: ACTB (actin beta) anti-
body (1:2000) (CST, 4967), GABARAP (E1J4E) antibody
(1:2000) (CST, 13733), Drosophila p-Akt1 (Ser505) (1:1000)
(CST, 4054), AKT1 (Pan) (1:2000) (CST, 4691), and HRP-
conjugated secondary antibodies (Jackson ImmunoResearch,
711-035-152). For Atg8a lipidation, flies were first transferred
to centrifuge tubes containing 1x laemmli buffer (Bio-Rad
Laboratories, 1610737) (10 µl buffer for each milligram of
fly), and heated at 100°C for 3 min. The samples were then
homogenized and heated again at 100°C for 3 min. After the
centrifuge at 14000 x g for 5 min, supernatants were collected
and loaded onto Mini-PROTEAN precast gels (Bio-Rad
Laboratories, 456–1095). Following incubation with primary
and secondary antibodies, the blots were visualized with
Pierce ECL Western Blotting Substrate (Thermo Fisher
Scientific, PI34577). For Akt1 phosphorylation, RIPA lysis
buffer (Thermo Fisher Scientific, PI36978) was used to extract
protein samples.
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Bafilomycin A1 and chloroquine treatment
For bafilomycin A1 treatment, semi-intact hearts were incu-
bated with 100 nM of bafilomycin A1 (Fisher Scientific,
AAJ61835MCR) in artificial hemolymph (buffer receipt in
[22]) for 2 h at room temperature prior to the appropriate
immunostaining. DMSO was used as a control.
For chloroquine treatments, 100 µl of 20 mM chloroquine
diphosphate salt, CQ (Fisher Scientific, ICN19391925) was
added onto the fly food. Flies were fed with chloroquine for
at least 24 h prior to the cardiac analysis or the western blots.
To test the toxicity of CQ treatment, we performed a survival
analysis by feeding ywR flies with 20 mM CQ and observed
the mortality within a period of within two weeks (about 100
flies per treatment). Flies were transferred to fresh CQ food
every day and fly mortality was recorded daily.
Demography and survival analysis
Newly enclosed female flies were allowed to mate for two
days, then separated from males and assigned to replicate
one-liter demography cages at a density of 100–125 flies per
cage. Three independent cages were set-up per genotype.
Food was changed every 2 d, at which time dead flies were
removed from the cage and counted. Survival analysis was
conducted with JMP statistical software (SAS Institute), and
data from replicate cages were combined. Mortality distribu-
tions were compared by Log-rank test.
Statistical analysis
GraphPad Prism (GraphPad Software) was used for statistical
analysis. To compare the mean value of treatment groups
versus that of control, either student t-test or one-way
ANOVA was performed using Tukey multiple comparison.
The effects of mutants during aging were analyzed by two-way
ANOVA, including Tukey multiple comparisons test. In
SOHA analysis, the outliers were identified using Robust
regression and Outlier removal (ROUT) method (Q = 1%)
prior to the data analysis.
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